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| Summary |
Voltage-gated sodium channels constitute a group of membrane 
proteins widely distributed thought the body. In the heart, there 
are at least six different isoforms, being the Nav1.5 the most 
abundant. The channel is composed of an α subunit that is formed 
by four domains of six segments each, and four much smaller β 
subunits that provide stability and integrate other channels into 
the α subunit. The function of the Nav1.5 channel is modulated 
by intracellular cytoskeleton proteins, extracellular proteins, 
calcium concentration, free radicals, and medications, among 
other things. The study of the channel and its alterations has 
grown thanks to its association with pathogenic conditions such 
as Long QT syndrome, Brugada syndrome, atrial fibrillation, 
arrhythmogenic ventricular dysplasia and complications during 
ischemic processes. 
Keywords: NAV1.5 Voltage-Gated Sodium Channel; Long 
QT syndrome; Brugada syndrome (MeSH).
León-Ariza HH, Valenzuela-Faccini N, Rojas-Ortega AC, Botero-Rosas 
DA. Nav1.5 cardiac sodium channels, regulation and clinical implications. 
Rev. Fac. Med. 2014;62(4):587-92. http://dx.doi.org/10.15446/revfacmed.
v62n4.44015.
Resumen
Los canales de Sodio dependientes de voltaje constituyen un 
grupo de proteínas de membrana ampliamente distribuidas 
en el cuerpo humano. En el corazón se dispone de al menos 
seis diferentes isoformas de estos canales: los Nav1.5 son los 
más abundantes. El canal está constituido por una subunidad 
α, formada por cuatro dominios, cada uno de estos con seis 
segmentos y cuatro subunidades β mucho más pequeñas que 
estabilizan la estructura e integran la subunidad α de otros canales. 
La función del canal Nav1.5 se ve modulada por proteínas del 
citoesqueleto, proteínas extracelulares, concentraciones de calcio, 
radicales libres, medicamentos, entre otros. El estudio del canal 
y sus alteraciones se ha incrementado gracias a la asociación de 
este con condiciones patológicas como el síndrome de QT largo, 
el síndrome de Brugada, la fibrilación auricular, la displasia 
ventricular arritmogénica y por las complicaciones de en procesos 
isquémicos.
Palabras clave: Canal de Sodio Activado por Voltaje NAV1.5; 
Síndrome de QT Prolongado; Síndrome de Brugada (DeCS). 
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Introducción
The great majority of the cells in the organism need to be 
depolarized in order to fulfill their functions. This is the case 
for excitable tissues like neurons, and skeletal and cardiac 
muscle. Here, the sodium ion (Na+) is principally responsible 
for the process, as described by Hodgkin and Huxley in 1952 
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(1). Voltage-gated sodium channels, which differ in their alpha 
subunits (2), are responsible for Na+ flow. The difference in 
subunits of these channels has permitted their organization into 
isoforms of these channels that are mainly found in the central 
nervous system (Nav1.1 - 1.3 and Nav1.6), in the peripheral 
nervous system (Nav1.7 - 1.9), in skeletal muscle (Nav1.4), in 
myocardial muscle (Nav1.5) (3,4), and in the uterus, astrocytes 
and hypothalamus (Nax) (5). A large part of the classification 
process was possible thanks to the sensitivity of the proteins 
to tetradotoxin (TTX) (6,7), to which some Nav, like 1.5, 1.8 
and 1.9, are more resistant and others, like Nav1.1 – 1.4 and 
1.6, are more sensitive (3,8). 
The cardiac muscle cells depend on a rapid influx of 
sodium (INa) to generate an action potential. This permits 
Kv4.2/4.3 Transient potassium 
current. Exit of chlorine ions
a depolarization of the tissue and conduction of the impulse 
through the myocardial cells (9,10). Until some time ago, it 
was thought that the INa in the heart depended solely on one 
type of channel (Nav1.5) (Figure 1). However, it is now clear 
that there are at least six different types of voltage-dependent 
sodium channels in cardiac contractile cells, Nav1.1 - 1.6, 
distributed at both the ventricular (11) and atrial levels (12). 
Furthermore, Nav1.8 channels have been also described that 
are related to neuronal regulation of the firing rate. They are 
located essentially in the electrical conduction system of the 
heart (13). Through the use of immunohistochemistry, it has 
been established that the Nav1.5 are especially located on the 
cellular surface of contractile, improving conduction between 
them. In addition, they are proportionally more abundant 
(88%) in the cellular surface (14-17). 
Cav1.2 Slow calcium current 
Kv7.1 Slow delayed rectifier 
current of potassium




Kv7.1 Slow delayed rectifier 
current of potassium          
Kv11.1 Rapid delayed rectifier 
current of potassium
Figure 1. Location of Nav1.5 channels in the process of depolarization of cardiac muscle. 
Due to the importance of the Nav1.5 channel, this review 
presents its fundamental characteristics and its principle 
physiological regulation mechanisms to finally link alterations 
of the channel with congenital and acquired cardiomyopathies. 
The search for articles was carried out in the following 
databases: Pubmed, ScienceDirect and Scielo. The terms 
Nav1.5, Brugada syndrome, and atrial fibrillation (Nav1.5, 
síndrome de brugada, fibrilación auricular), in both English 
and Spanish, were used between January 2004 and February 
2014 for the article search. Five articles from before 2004 
were included because of their contribution to the theoretical 
construction. 
Structure of the Nav1.5 channel
The Nav1.5 channel is a protein with a glycosylated 
membrane, codified by the gene SCN5A in the chromosome 
3p21. It has a weight of 220 kDa and is made up of between 2014 
y 2016 amino acid residues (14,18,19). This protein is formed 
by the homologous domains DI-DIV. Each one contains six 
transmembrane segments, S1-S6 (15). The α-subunit contains 
an amine group (N) and an intracellular carboxyl terminal 
domain (C), and three intracellular, called L1, L2, and L3 that 
connect the four domains (20). The most studied of the segments 
is S4, which is positively charged thanks to the presence of la 
arginine and lysine, followed by two hydrophobic residues. This 
segment is associated with the activation of the channel (21). 
Furthermore, the inactivation of the channel is to be 
attributed to the DIII and DIV intracellular loops, where a 
sequence of three amino acids — isoleucine-phenylalanine-
methionine— is fundamental. Also important in the 
inactivation is the carboxyl terminus sequence (14, 15). 
Between S5 and S6 of every domain is a loop that reintroduces 
itself in the lipid bilayer in the extracellular side of the pore 
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formed by a narrow selective filter for the sodium ion, with two 
characteristic sequences of amino acids: aspartate-glutamate-
lysine-alanine and glutamate-glutamate-aspartate-aspartate 
(6) (Figure 2).






Cytoskeleton and gap junctions
In addition to the α-subunit, the channel consists of the subunits 
β1-β4, which are proteins of 30-35 kDA (14). Its structure is 
characterized for being a transmembrane α-helix chain with a 
N-terminal extracellular fold similar to the one in immunoglobins 
and a short intracellular C terminus. The β1 and β3 subunits 
attach to the alpha-subunits in a non-covalent manner, while the 
β2 and β4 subunits attach through disulfide bonds. The function 
of these subunits is to modulate the opening and closing of the 
channel by interacting with the extracellular matrix and with the 
cytoskeleton at the same time. This influences the localization of 
these channels in the cell surface (12,16). Recently, it has been 
demonstrated that the β-1 subunit promotes interaction between 
the alpha subunits of the cardiac sodium channels Nav1.5 (20,22).
Biological characteristics of the Nav1.5 channel
As was previously mentions, the INa in the heart are produced 
mainly by the Nav1.5 channels, which are responsible for the 
creation of the action potential and the rapid depolarization of 
the heart (20,23). The Nav1.5 channels can be found in three 
states: closed, when the membrane has a resting potential; 
open, during depolarization; and inactive, during the state 
of non-conductivity. Inactivation is carried out thanks to an 
“inactivation gate” that is found in the intracellular loop that 
joins domains III and IV (6, 21). Furthermore, recovery in the 
inactivation state occurs during re-polarization in diastole (15). 
Different experimental studies both in humans and animals 
have shown the presence of Nav1.5 channels not only at 
the level of cell membranes in cardiac muscle but also in 
intercalated discs, in lateral cell membranes, and in T-tubules 
(15). Also, the presence of these channels has been described 
in atrial myofibroblasts similar to those in excitable cells, 
which can modify their properties in pathological conditions 
(24). The Nav1.5 channels are distributed in an non-uniform 
manner along the ventricular wall, being more abundant in the 
endocardium than the epicardium, which generates important 
electrophysiological changes at the transmural level (25). 
This could explain the differences in the clinical behavior of 
subepicardial and subendocardial infarctions. 
Interestingly, it has been found how sodium channels interact 
and are modulated by the mechanical properties of the membrane 
and cytoskeleton. This occurs because the Nav1.5 channels have 
a mechanosensitive property which means that the alterations in 
cellular mechanical behavior lead to changes at the channel level. 
For example the level of stretching produces directly proportional 
changes in its activation and inactivation (23). As such, changes at 
the mechanical level, like the behavior of blood volume (preload), 
lead to changes in the firing rate of the sinuatrial node, atrial-
ventricular excitability, and conduction speed (26). Dystrophin 
and syntrophin, thanks to their relationship with the cytoskeleton, 
participate in the regulation of the Nav1.5, and are responsible 
for patients with muscular dystrophy presenting cardiopathies 
that are partially compensated for through utrophin (27,28).
Another widely recognized regulator of Nav1.5 channel 
function is calcium. This ion modulates the density of sodium 
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channels without changes in the kinetic properties of the myocytes 
(29). The intracellular calcium level modulates that inactivation of 
the Nav1.5 in three regions of the channel: between the domains 
DIII and DIV, in two regions of the carboxyl terminus, and in 
isoleucine and glutamine sequences known as the IQ-motif 
(30). In addition, the calcium-calmodulin (CaM) interaction is 
fundamental for the activation of the calcium-calmodulin kinase 
(CAMKII), with which it interacts in the L1 region of the Nav1.5. 
Thus, the L1 domain is the predominant substrate for the CaMKII. 
7 sites of phosphorylation have been found in 5 regions of the L1 
domain (20,31). Although the results of the different studies are 
contradictory, it appears that the interaction of the Nav1.5 with 
the CAMKII slows the inactivation of the channel. 
The intercalated disc serves as a meeting point of the 
proteins that are relevant for excitability, propagation, and the 
mechanical joining of cardiomyocytes. This converts it into a 
site of interaction between the sodium channels and the gap 
junctions. Specifically, we are referring to two interactions of 
proteins that relate the sodium channel and the gap junctions: 
conexin43 (Cx43) and ankyrin-G. This communication is 
important because it determines the intensity of the sodium 
current between the cardiomyocytes (32). 
An increase in the polymerization of tubulin of the 
cytoskeleton, like the one caused by the anticarcinogenic 
agent taxol (TXL) reduces the expression of Nav1.5 in the 
sarcolemma, and reduces the INa in a process that may or 
may not involve the β1 subunit by producing a reduction in 
fast inactivation in the Nav1.5 + β1 interaction (33).
Another Nav1.5 modulator is the presence of nicotinamide 
adenine dinucleotide (NADH) through protein kinase C (PKC), 
in such a way that increases in NADH and free oxygen radicals 
(ROS) leads to the reduction of INa (34).  Nav1.5 has also 
demonstrated its extrinsic regulation through medications: 
lidocaine is a blocker of Nav1.5, reason for which it is used as an 
antiarrhythmic (35); ranolazine blocks the mechanosensitivity of 
the channel and has and has an antianginal effect (26); propanolol 
—a beta-blocker— alters the cardiac sodium channel (36); and 
opioid medications interact with omega cardiac receptors that 
regulate the Nav1.5 while producing inhibition (35). 
Many other structural and induced interactions between Nav1.5 
and proteins have been described. For a more detailed review of 
these, we suggest consulting Rook et al (14). 
Clinical application
The sodium channels Nav1.5 are, without a doubt, the 
most studied with regard to both congenital and acquired 
conditions. The first congenital pathological condition in 
which an association with mutations of the gene (SCN5A) 
was described was a form of the long QT syndrome (type 3) 
that predisposes sufferers to the development of ventricular 
tachycardia and torsades de pointes. In this case, the mutation 
of the channel leads to a slight prolongation of its action that 
delays the re-polarization phase (37). A similar phenomenon 
has also been described in the Brugada syndrome, which has a 
electrocardiographic pattern characteristic of supraunleveling 
for the ST segment in V1 to V3 and a morphology with right 
bundle branch block. It is related to sudden death (38). The 
prevalence of Brugada syndrome is not completely clear, since 
if may present in a silent or undiagnosed way. It has been 
estimated that there are around 5 cases per 10 000 people, and 
that it is the cause of death in 4-12% of sudden deaths (39). 
Other pathological conditions associated with the Nav1.5 
subunit include atrial fibrillation (AF). This is one of the most 
common persistent arrhythmias. It involves alterations to the 
sodium channel leading to an increase in conduction time that, 
in conditions of vagal stimulation, are prolonged even more, 
leading to the development of AF (40-44). It has also been 
reported that mutations of the β1 y β2 of the sodium channel 
are associated with AF and, in this case, a reduction in INa has 
been proposed as part of its pathogenesis (45). Mutations in the 
SCN5A gene have also been associated with the development 
of ventricular arrhythmogenic dysplasia and, thus, a greater 
tendency toward the development of ventricular arrhythmias 
like ventricular tachycardia and fibrillation (46-50). 
The development of ventricular and atrial arrhythmias 
has been linked, in patients with heart failure, to the elevated 
presence of angiotensin II and hypoxia. These induce the 
activation of nuclear proteins like RBM25 and LUC7L3 that 
produce splicing in the SCN5A gene that is responsible for 
coding for the Nav1.5. This leads to a lesser expression of this 
protein and the development of arrhythmias (51). 
In ischemic processes, extracellular acidosis interacts with 
Nav1.5, altering the states of rapid and slow inactivation. This 
increases the persistence of INa, something that contributes to 
the development of arrhythmias (52). Furthermore, recently the 
presence of coxsackievirus receptors can alter sodium currents 
in the Nav1.5, altering its function, which leads, once again, to 
a predisposition to the developments of arrhythmias in patients 
with coronary heart disease (53). Increases in NADH and ROS 
leads to a reduction in INa (blocks, arrhythmias), a commonly 
observed phenomenon in heart failure (34).
Conclusions
Nav1.5 sodium channels are no longer seen as a simple set 
of proteins that regulate sodium flow into the cell. Currently 
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it is known that its function depends on the interaction with 
the cytoskeleton, second messengers, and other ions, such as 
calcium, that play an important role in pathological conditions. 
Much more research is needed in order to understand the 
biological nature of the Nav1.5 channel, which allows, among 
other applications, pharmacological development to prevent 
electrophysiological complications in acute myocardial 
infarction and to avoid the complications of conditions such 
as long QT syndrome or Brugada syndrome.
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